Novel pathomechanisms of ventilator-induced neonatal lung injury: new targets to overcome ongoing challenges
Preserving conceptual clarity: why hypersensitivity pneumonitis should remain a separate entity from bronchiolocentric interstitial pneumonia
Substituting bronchiolocentric interstitial pneumonia for hypersensitivity pneumonitis: a word of caution
Reply: Bronchiolocentric interstitial pneumonia is a morphological term used for lung biopsy and chest imaging pattern and is not a substitute for hypersensitivity pneumonitis
Cooling the flames, clearing the airways: systemic inflammation in the era of elexacaftor/tezacaftor/ivacaftor
Challenges in harmonising terms and patterns among interstitial pneumonias: enter idiopathic bronchiolocentric interstitial pneumonia
Classification of interstitial pneumonias: ready for the future or stuck in the past?
Enhancing SABRE's clinical utility in idiopathic pulmonary fibrosis: addressing methodological concerns
Reply: SABRE for airway quantification in idiopathic pulmonary fibrosis: clarifications, limitations, and next steps
https://bit.ly/3VVacfK
Quantitative airway biomarkers in idiopathic pulmonary fibrosis: SABRE's promise, validation gaps, and the road to clinical adoption
Whole lung directed anti-muscarinic therapy improves small airway dysfunction in COPD patients
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma
For a decade, anti-Interleukin 5/Receptor alpha (IL5/Rα) has been available for severe asthma, with marked reductions in exacerbation rates and maintenance oral corticosteroid (mOCS) burden. However, little is known about the long-term, real-world sustained remission. We aimed to assess the stability of response to anti-IL5/Rα over five years.
Reduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk
Lung transplant recipients with lower club cell secretory protein (CCSP) levels in the bronchoalveolar lavage fluid (BALF) early posttransplantation are at increased risk for chronic lung allograft dysfunction (CLAD). For CLAD risk stratification, we previously identified a potential risk threshold for reduced CCSP (protein-normalized CCSP <8.63 ng·µg). Here, we aim to validate this association in an independent patient set from a prospective observational cohort.
Impact of positive airway pressure therapy on pulmonary artery pressures in obstructive sleep apnea or obesity hypoventilation syndrome: a systematic review and meta-analysis
There is limited and conflicting evidence on the impact of obstructive sleep apnea and its treatment with positive airway pressure (PAP) therapy on pulmonary hypertension (PH).
Shared pathways, shared risks: the overlap of interstitial lung abnormalities and coronary heart disease
Reply to: Enhancing methodological rigour in meta-analyses of renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Lower lobe mucus plug distribution and future respiratory exacerbations in tobacco-exposed individuals with and without COPD
